Federation des caisses Desjardins du Quebec’s PAVmed PAVM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3	Closed	-$20	–	3056
2025 Q4	$20	Hold	3	–	–	﹤0.01%	2852
2025 Q3	$41	Hold	3	–	–	﹤0.01%	2837
2025 Q2	$57	Hold	3	–	–	﹤0.01%	2685
2025 Q1	$68	Buy	+3	New	+$62	﹤0.01%	2610

Other funds holding PAVM

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PAVM Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 3 shares — an estimated $20 sold.

Federation des caisses Desjardins du Quebec first reported a position in PAVM in Q1 2025 and held it in 4 quarters. The position peaked at $68 in Q1 2025. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

Federation des caisses Desjardins du Quebec reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 3 PAVmed shares in Q1 2026, an estimated $20.
Federation des caisses Desjardins du Quebec first reported a position in PAVmed in Q1 2025 and held it in 4 quarters.
Federation des caisses Desjardins du Quebec's PAVmed position peaked at $68 in Q1 2025.
20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.